10x Genomics Inc.

TXG | NASDAQ

Price Alert Chart Builder DCF Calculator

$81.70

+$2.60 (+3.29%)

Sep 22, 2026, 1:11 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $10.04B

Enterprise Value $9.57B

Beta 2.08

Average Volume 3.1M

Shares Outstanding (Diluted) 129.98M

Shares Change YoY 4.4%

Institutional Ownership 97.64%

Exchange NASDAQ

ISIN US88025U1097

Price Performance

Price Change 1M 25.2%

Price Change 3M 148.2%

Price Change 6M 278.3%

Price Change YTD 375.9%

Price Change 1Y 506.6%

Price Change 3Y 91.3%

Price Change 5Y -48.7%

1M CAGR (ann.) 52.0%

1Y CAGR (ann.) 496.1%

5Y CAGR (ann.) -14.1%

All-Time CAGR 5.9%

Valuation

PE Ratio -134.07

Forward PE N/A

PEG Ratio 0.29

Forward PEG 39.00

PS Ratio 16.28

Forward PS 14.80

PB Ratio 12.16

P/FCF Ratio 82.70

P/Adj. FCF Ratio 442.49

P/OCF Ratio 80.71

EV/Sales 15.51

EV/EBIT -1,158.90

EV/EBITDA 341.70

EV/FCF 78.80

Earnings Yield -0.8%

FCF Yield 1.2%

Adj. FCF Yield 0.2%

Financial Health

Net Cash $552.03M

Total Debt $78.8M

Cash & Short-Term Investments $552.03M

Total Assets $1.03B

Current Ratio 5.69

Quick Ratio 5.25

Debt / Equity Ratio 0.10

Debt / EBITDA 2.81

Debt / FCF 0.65

OCF / Debt 1.61

Interest Coverage -29,461.33

Altman Z-Score 28.59

Piotroski F-Score 4

Margins & Profitability

Gross Profit Margin 70.0%

Operating Profit Margin -14.3%

EBITDA Margin 4.5%

Net Profit Margin -12.2%

FCF Margin 19.7%

Adj. FCF Margin 3.7%

SBC / Revenue 16.0%

SBC Impact (per share) -81.3%

Returns

Return on Assets -7.3%

Return on Equity -9.3%

Return on Invested Capital -9.6%

Return on Capital Employed -9.7%

Return on Tangible Assets -7.8%

Historical Growth (CAGR)

Revenue CAGR 3Y 2.8%

Revenue CAGR 5Y 8.7%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 64.8%

EPS CAGR 5Y 17.6%

EPS CAGR 10Y N/A

FCF CAGR 3Y 160.4%

FCF CAGR 5Y 275.7%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 22

EPS Growth Next 3Y 16.9%

Revenue Growth Next 3Y 9.2%

Earnings Date Nov 4, 2026

EPS Estimate (next Q) -$0.27

EPS Growth Est (next Q) 22.7%

Revenue Est (next Q) $147.7M

Revenue Growth Est (next Q) -0.9%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $53.33

Price Target Upside -32.6%

Cash Flow

Operating Cash Flow $127.09M

Free Cash Flow $121.44M

Adj. Free Cash Flow $22.7M

FCF Per Share $0.93

OCF Per Share $0.98

OCF/S Ratio 20.6%

Income Statement

Revenue $616.91M

Gross Profit $432.03M

Operating Income $-88.38M

EBITDA $28M

Net Income $-75.13M

EPS (Diluted) -$0.59

Revenue / Employee $523.69K

Profit / Employee $-63.77K

Employees 1,178